However, whether hepatic PTP1B influences hepatic inflammation and liver fibrosis through the phosphorylation of AMPK and potential PTP1B inhibitors are suitable for treating fibrotic liver injury remain to be identified. This evidence concerns the gene PRKAA1 and Hepatic fibrosis.